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Abstract
Background: Intergenic splicing resulting in the combination of mRNAs sequences from distinct
genes is a newly identified mechanism likely to contribute to protein diversity. Few cases have been
described, most of them involving neighboring genes and thus suggesting a cotranscription event
presumably due to transcriptional termination bypass.
Results: We identified bovine chimeric transcripts resulting from cotranscription and intergenic
splicing of two neighboring genes, PPARG and TSEN2. These two genes encode the Peroxisome
Proliferator Activated Receptors γ1 and γ2 and the tRNA Splicing Endonuclease 2 homolog and are
situated in the same orientation about 50 kb apart on bovine chromosome 22q24. Their relative
position is conserved in human and mouse. We identified two types of chimeric transcripts
containing all but the last exon of the PPARG gene followed by all but the first exon of the TSEN2
gene. The two chimers differ by the presence/absence of an intermediate exon resulting from
transcription of a LINE L2 sequence situated between the two genes. Both transcripts use canonical
splice sites for all exons coming from both genes, as well as for the LINE L2 sequence. One of these
transcripts harbors a premature STOP codon and the other encodes a putative chimeric protein
combining most of the PPARγ protein and the entire TSEN2 protein, but we could not establish
the existence of this protein.
Conclusion: By showing that both individual and chimeric transcripts are transcribed from PPARG
and TSEN2, we demonstrated regulation of transcription termination. Further, the existence and
functionality of a chimeric protein harboring active motifs that are a priori unrelated is hypothesized.
Background
It is now well known that diversity at the protein level can
result from different positions of transcriptional start and
termination of a single gene, alternative splicing and post-
translational modifications. However, there is now evi-
dence that an additional level of diversity may also exist
by the production of mRNAs that combine sequence
information from different genes, also known as inter-
genic mRNAs. Various mechanisms appear to be involved
in this process and can be classified in two categories (1)
trans-splicing events between pre-mRNAs of distinct
genes and (2) long transcription events across neighbor-
ing genes that normally act as independent transcription
units. The latter case has been described for a number of
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genes including HAI-2 and H2RSP [1], the CYP2C locus
[2], GALT and IL-11Rα [3], P2Y11 and SSF1 [4], UEV1 and
Kua [5], 4E-BP3 and MASK [6]. In all these cases, chimeric
mRNAs that are produced might encode proteins harbor-
ing functional domains that are usually not encountered
on a single protein. However, although the chimeric tran-
scripts appear to be present at a comparable level as single
gene transcripts, the in vivo existence of chimeric proteins
has not been confirmed so far, suggesting that the transla-
tion of chimeric transcripts might be subjected to a nar-
row regulation.
We describe here the existence of bovine chimeric tran-
scripts involving the Peroxisome Proliferator Activated
Receptor Gamma (PPARG) gene and the neighboring
gene, recently identified in human as the TSEN2  gene
(tRNA Splicing Endonuclease 2 homolog) [7]. These two
genes are situated 50 kb from each other on human chro-
mosome 3p25 and their respective position is conserved
on bovine chromosome 22q24 (this paper, [8]). The
PPARG  gene has been intensively studied because it
encodes two nuclear receptors (PPARγ1 and PPARγ2)
implicated in the regulation of a variety of cellular proc-
esses, such as cell cycle control, carcinogenesis, inflamma-
tion, atherosclerosis and mostly adipogenesis [9-11]. The
reason why we decided to study this gene in cattle is
because of its presumed implication in the amount of adi-
pose tissue associated to the meat. The TSEN2  gene
encodes a protein involved in the formation of a human
endonuclease complex whose function is the removal of
introns from pre-tRNAs,. The complex is a heterotretramer
formed by four distinct proteins that are well character-
ized in yeast [12] but only very recently identified in
human [7]. We identified two types of chimeric transcripts
containing all but the last exon of the PPARG gene fol-
lowed by all the coding exons of the TSEN2 gene (exons 2
to 12). One chimeric transcript harbors a continuous
open reading frame resulting from a perfect connection of
the two coding regions, but lacks the region encoded by
the last exon of PPARG. The other chimeric transcript has
an additional exon between the two regions, resulting
from the transcription of a repetitive sequence situated in
Identification of chimeric transcripts between the bovine PPARG and TSEN2 genes Figure 1
Identification of chimeric transcripts between the bovine PPARG and TSEN2 genes. A-Correspondance between the bovine EST 
BF041169 and human chr3p25 genomic sequence and bovine mRNAs. B- RT-PCR experiment performed on bovine cDNA 
using primers designed on PPARG exon 5 and TSEN2 exon 2: structure of the two amplified fragments.
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the 5' region of the TSEN2 gene and introducing a stop
codon in the coding sequence.
We show here that, in cattle, both genes can be expressed
as independent transcriptional units or as a hybrid
PPARG-TSEN2 transcript devoid of the last exon of PPARG
and the first exon of TSEN2. This chimeric transcript har-
bors an open reading frame encoding a putative chimeric
protein combining domains from the two distinct pro-
teins but we could not show any evidence of the existence
of this protein. Chimeric transcripts between these two
genes cannot be detected in human or mouse.
Results
The PPARG and TSEN2 genes form chimeric transcripts 
in cattle
When searching in the bovine EST database for ESTs cor-
responding to the PPARG  gene, we found one EST
sequence [Genbank:BF041169] containing the end of
PPARG exon 5 followed by a sequence completely unre-
Structure of the bovine PPARG and TSEN2 genes and transcripts Figure 2
Structure of the bovine PPARG and TSEN2 genes and transcripts. A- Genomic structure of the two genes. B- Structure of the 
normal transcripts from both genes. C- Structure of the short and long chimeric transcripts and partial coding sequence at the 
junction between the two genes (untranslated exons are in red, translation start and stop are indicated).
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lated to the PPARG  gene. A BLAST search with this
sequence revealed a high level of identity with two regions
on the human genome : (1) the 174 bp situated down-
stream the PPARG exon 5 on the EST show 76% identity
with a short sequence situated 50 kb downstream the
PPARG gene on human chromosome 3 and (2) the next
215 bp show 72% identity with the second exon of the
TSEN2 gene, situated 6258 bp further down on the same
chromosomal region (Figure 1A). The exon junctions are
perfectly conserved for PPARG exon 5 and TSEN2 exon 2
and the 174 bp region between the two exons on the EST
sequence appears to correspond on the human genome to
a LINE L2 interspersed repeat.
The  TSEN2  gene [Genbank:NM_025265] was recently
identified in human [7]. It includes 12 exons spanning
approximately 50 kb on human chromosome 3p25 and
encodes a 465 amino acid protein. The start codon is situ-
ated in exon 2. This gene was not characterized in cattle.
We performed a BLAST search against the bovine EST
database using the human mRNA sequence as target and
identified several bovine ESTs corresponding to parts of
the  TSEN2  gene [Genbank:CK963264, Gen-
bank:AV662447, Genbank:AW358633, Gen-
bank:AW358637]. Primers were designed from these EST
sequences and RT-PCR experiments were performed in
order to confirm the existence of this transcript and get the
full cDNA sequence. A 1450 bp cDNA sequence [Gen-
bank:DQ256761] was amplified using total RNA from
various bovine tissues including liver, brain, skeletal mus-
cles, spleen and heart, suggesting the ubiquitous expres-
sion of the gene. The bovine TSEN2 cDNA shows 77%
sequence identity with the human cDNA from exon 2 to
exon 12, which correspond to the coding sequence. It
encodes a 459 amino acid protein displaying 72%
sequence identity with the human protein. The untrans-
lated exon 1 is not conserved between human and cattle
(see below).
In order to confirm the observation of the chimeric EST,
we performed RT-PCR experiments on bovine cDNA
using primers designed on PPARG  exon 5 and TSEN2
exon 2. RT-PCR was first performed on cDNA from bovine
subcutaneous adipose tissue (Figure 1B). Two different
PCR products were obtained and sequenced. Both frag-
ments contained PPARG exon 5 followed by TSEN2 exon
2 and differed in the presence/absence of the 174 bp
observed on the EST BF041169 and identified as a LINE
L2 repeat. We then used primers from different regions of
both genes in order to establish if these chimeric tran-
scripts contain the whole coding sequence of PPARG and
TSEN2 genes. We amplified two types of chimeric tran-
scripts both containing PPARG exon 1 to 5 and TSEN2
exon 2 to 12, and differing by the presence or absence of
the LINE L2 repeat between PPARG exon 5 and TSEN2
exon 2 (referred to as long and short chimeric transcripts,
Genbank:DQ256760 and Genbank:DQ256759) (Figure
2). Both types of transcripts use canonical splice sites for
all exons coming from both genes.
The chimeric transcripts might be specifically expressed 
from the PPARG1 promoter
Two different transcripts differing in their 5' end are
expressed from the PPARG gene: PPARG1 (exons A1, A2,
and 1 to 6) and PPARG2 (exon B and 1 to 6). These two
transcripts result from the existence of two promoters [8]
(Figure 2A). We used forward primers specific of the
PPARG1  or PPARG2  transcripts together with a reverse
primer in the exon 2 of the TSEN2 gene to test if the chi-
meric transcripts are expressed from both promoters. We
did amplify transcripts spanning from PPARG exon A1 to
TSEN2 exon 2 but we failed to amplify any RT-PCR prod-
uct spanning from PPARG exon B to TSEN2 exon 2. The
experiment was repeated several times with different
primer sets, using primers that allowed the amplification
of the individual gene transcripts, and the results were
always the same.
Chimeric transcripts encode a putative truncated PPARG 
protein and a putative chimeric PPARG-TSEN2 protein
Both types of chimeric transcripts have an open reading
frame using the start codon from PPARG exon 1 and lack
the STOP codon of the PPARG gene situated in exon 6, the
only exon missing in the chimeric transcripts. In the short
chimeric transcript, the open reading frame is not inter-
rupted between PPARG exon 5 and TSEN2 exon 2 and
continues to the STOP codon in TSEN2 exon 12 (Figure
2C). The first 26 nucleotides of TSEN2 exon 2 are not
included in the normal coding region of the gene, but they
are perfectly inserted in frame with the coding sequence of
the PPARG gene. PPARG exon 5 is normally interrupted by
a phase I intron (intron that interrupts a codon between
the first and second nucleotide) but the connection with
TSEN2  exon 2 restores the codon and creates a short
region encoding 9 amino acids in frame with the coding
region of the TSEN2 gene. Consequently, the short chi-
meric transcript encodes a putative chimeric protein of
861 amino acids containing most of the PPARγ1 protein
and all the Sen2 protein, plus nine additional amino-
acids separating them.
In the long chimeric transcript, the presence of the LINE
L2 repeat between PPARG exon 5 and TSEN2 exon 2 cre-
ates a premature termination codon (Figure 2C), leading
to a putative truncated PPARγ protein lacking the last 82
amino acids that are encoded by exon 6, but harboring
instead 6 amino acids resulting from the translation of the
first 18 nucleotides of the LINE L2. However, because of
the presence of a premature termination codon, this tran-
script may be subjected to degradation by RNA surveil-BMC Genomics 2006, 7:71 http://www.biomedcentral.com/1471-2164/7/71
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Comparison of the structure and sequence of the TSEN2 gene 5'end between human and cattle Figure 3
Comparison of the structure and sequence of the TSEN2 gene 5'end between human and cattle. A- Genomic structure of the 
region with the alternative untranslated exons 1 and 1bis and corresponding cDNAs. Stars indicate the presence of donor/
acceptor splice sites. B- Sequence alignment of the LINE L2 repeat sequence. Arrows indicate the beginning and end of the 
LINE L2 as detected by Repeat Masker in both species. C- 5'untranslated exons 1 and 1bis (partial sequence) of the TSEN2 
gene. Regions that are transcribed are outlined in grey, splice sites are in bold/underlined.
human     CTCTGCGGCTGCGCACTCGGCTGGCTTTGCGGCCGCACTGCTTGACGGCAGC-GGTGTCC 
bovine    CTCCACGGCTGCGCAGTCGCCCGGCTTTGCGGCCGCGCTGCTTGACGGCAGCTGGTGTCC 
***  ********** *** * ************** *************** *******
human     GCCCCAC-GGCCGGCGTTGCCGGGGTAACGGCGAGCGCGTG----GGGCCAAGAAAGgta 
bovine    GCCCCCCCGGCCGGCGTTGCCGGGGTAACGTTGCGCGCGTGCCGGGGGCGGAGGAAGgta    
***** * **********************  * *******    ****  ** ****** 
human     agg-gccct---------GGG--CGAGGAA---------------AGCGCGGCCCTTTCC 
bovine    aggtaccctggggcccccgggagcgggaagcaattcgaggcgacgagcgcggtggccgcg 
***  ****         ***  ** * *                *******   * 
human     GAGTTTGGTG---TTTTGCAGCGAAAGGAAATCTCGC-TCTTCCGAAAGTCCTCC---// 
bovine    gccttcggggaggctcgtccgcgggaagaggcgtcgccttttccgaaagctctcc---// 
*  ** ** *    *   * ***  * **    **** * *********  ****  
human    //--AGCCTCTGGTGGAGTTCGGTCGGGTGTGGGGGTAGTCAAGGAAAGAAGCAAAGGGgt
bovine   //--ggttactagcagggtt--gctggggctgtaggagcccggcaaaagggacagggttat 
*   ** *  * ***  *  ***  **  **    *    ****   **  *   *
human     aagacagggagttaggaattggcggggcccctaacgctgttggggtgcgcagtttatttt 
bovine    gacacggggggttgggagtctgttgagcccttgacttttttttttttttttttgctcatt 
* ** *** *** *** *  *  * **** * **  * **    *      *  **  
C: exon 1 and exon 1bis
human     acagggacaacacatgccatgccagactactgcagagcacagaggcaagtcacccaagca
bovine    actacttcttttcagGGGGCACCAGACTATCCTAGAACACAGAGGAATGTCACCCAAGGC
**     *    ** *     ********    *** ******** * **********
human     ggtctgggaaggcaaga---agtctcctggaagaggtgatatttgagctgagacctaaag
bovine    AGCCTGGGGAAGCAAGAGGAAGTGTCCTG-AAGAAGAGAGGTCTGAGCTGAGACCTACAG
* ***** * ******   *** ***** **** * **  * ************** **
human     gctgaccaggaattactgcagctaacagaggggaggga------acatagaggcaacagc
bovine    GGCGACCAGGAGTCACTGCTGCACACCCAGGAGAAGGATGGTCCAGGTGGCAGCCACAGT
*  ******** * ***** **  **  *** ** ***      *  * *  ** ****
human     atgcgtgaaggaatggaggca--agaacattggcagaagtccaaaattcaacatccatca
bovine    GTTCACGAAGgtccggagacaggagaaggttggggaaggtccggatttcagagcccgt--
* *  *****   **** **  ****  ****   * ****  * ****    ** *  
B: LINE L2 sequence
A
2 1
1bis 1 2
~1800 bp
~800bp
LINE L2
~4800bp
~6000bp
1 2
1 2
1bis 2
TSEN2 mRNA
(NM_025265)
EST BI762668
EST BX385508 
bovine genomic
human genomic
** *
* *
*
LINE L2
bovine cDNA
Exon 1
Exon 1bisBMC Genomics 2006, 7:71 http://www.biomedcentral.com/1471-2164/7/71
Page 6 of 11
(page number not for citation purposes)
lance mechanisms such as mRNA decay (NMD) before
being translated.
The organisation of the PPARG-TSEN2 genomic region is 
conserved between human chromosome 3p25 and bovine 
chromosome 22q24
We then decided to characterize and partially sequence
the corresponding bovine genomic region in order (1) to
establish if the relative position of the two genes is the
same in cattle and human, (2) to determine if the LINE L2
repeat that is inserted in the long chimeric transcript is
conserved and why that this short sequence is occasion-
ally transcribed and (3) to localize the 5'untranslated
exon 1 of the bovine TSEN2 gene. We used a combination
of approaches to obtain the genomic sequence of this
region. We screened a bovine BAC library with four sets of
primers amplifying PPARG exon 5, PPARG exon 6, TSEN2
exon 2 and TSEN2  exon 3, respectively. Several BAC
clones were identified among which one clone (660H1)
was positive for the four primer sets and one clone
(660A10) positive with the three last primer pairs. The
fact that the 3'end of the PPARG gene and the 5'end of the
TSEN2 gene are present in the same BAC clones confirm
that they are close to each other in the bovine genome as
in the human genome. We subcloned and sequence sev-
eral regions from the BAC clones and supplemented them
using trace sequences from the bovine genome sequenc-
ing project (obtained at [13]). We obtained a 5847 bp
sequence containing the LINE L2 sequence present in the
chimeric transcripts, exon 1 and part of intron 1 of the
TSEN2  gene [Genbank:DQ256762], and a 2185 bp
sequence containing the end of intron 1, exon 2 and
beginning of intron 2 of the TSEN2  gene [Gen-
bank:DQ256763].
We aligned the human and bovine sequences for the 5'
region of the TSEN2 gene. The LINE L2 repeat is conserved
in sequence and position between human and cattle but
there are canonical splice sites at both ends in cattle only,
which might explain the fact that this sequence is present
in bovine transcripts (Figure 3A–B). The bovine untrans-
lated exon 1 present in the EST CK963264 and in our
cDNA sequence is situated 1.8 kb downstream of the LINE
L2 repeat. In human, there are two different exons 1 (here
referred to as exon 1 and exon 1bis). Exon 1 is encoun-
tered in two human ESTs and is similar to the bovine exon
1. Exon 1bis is present in the reference mRNA sequence
for the human TSEN2 gene [Genbank:NM_025265] and
is situated 11 bp downstream of exon 1. The bovine
sequence corresponding to the human exon 1bis is con-
served and the canonical splice site at the 3'end (GT) is
present in cattle as well (Figure 3C). However, we failed to
obtain any RT-PCR product containing this exon 1bis,
whereas we did amplify RT-PCR products harboring exon
1. The difference in size of the region between the con-
served LINE L2 sequence and exon 1 (1.8 kb in bovine, 0.8
kb in human) is due to the presence in cattle of species-
specific interspersed repeats, one LINE Bov B and two
SINEs, spanning approximately 1 kb.
We compared the bovine sequence to the corresponding
region in mouse (data not shown). The mouse cDNA
sequence [Genbank:NM _199033] contains an untrans-
lated exon 1 that is conserved with human and bovine
exon 1. There is no evidence in the genomic sequence of a
sequence that might be similar to exon 1bis. The LINE L2
repeat is not present in mouse either.
The PPARG and TSEN2 genes are expressed in cattle as 
independent transcriptional units or as a hybrid PPARG-
TSEN2 transcript
We used cDNA from a set of bovine tissues to test the
expression of the different transcripts. RT-PCR experi-
ments were performed using three sets of primers specifi-
cally amplifying regions present in PPARG transcripts only
(exon 5 to exon 6), TSEN2 transcripts only (exon 1 to
exon 5) and chimeric transcripts only (PPARG exon 5 to
TSEN2 exon 2). The expected fragments were amplified in
all tissues tested (Figure 4), suggesting the ubiquitous
expression of both genes as well as of the chimeric tran-
RT-PCR amplification of the PPARG and TSEN2 independent  (A, B) and fusiontranscripts (C) in bovine tissues (1 to 5 skel- etal muscles, 6 subcutaneous fat, 7 spleen, 8 testis,9 liver, 10  brain, 11 heart, N negative control) Figure 4
RT-PCR amplification of the PPARG and TSEN2 independent 
(A, B) and fusiontranscripts (C) in bovine tissues (1 to 5 skel-
etal muscles, 6 subcutaneous fat, 7 spleen, 8 testis,9 liver, 10 
brain, 11 heart, N negative control).
C PPARG exon 5 to TSEN2 exon 2
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B TSEN2 exon 1 to 5
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scripts. Both long and short chimeric transcripts were
present in all tissues tested but with variable proportion,
the band corresponding to the long transcript being very
faint in subcutaneous adipose tissue and brain. However,
the same experiment was conducted on the same set of tis-
sues from a different individual and these differences did
not appear, suggesting that they may be due to individual
variations and/or the quality of the RNA.
The chimeric transcripts are expressed at a lower level 
compare to the PPARG transcripts
We performed semi-quantitative RT-PCR experiments in
order to compare the level of expression of the chimeric
transcripts and the PPARG transcripts. Four different tis-
sues from the same animal were tested and the relative
expression of the different transcripts were normalized
using the GAPDH gene as control. The relative expression
levels of the PPARG transcripts (including both PPARG1
and PPARG2) and the chimeric (short and long) tran-
scripts are presented on Figure 5. Because of the high ratio
between the PPARG and chimeric transcripts, we used a
logarithmic scale in order to be able to display both values
on the same figure. This ratio varies from 124 in adipose
tissue to 34 in liver, with intermediate values in muscle
and diaphragm. The amount of both PPARG and chimeric
transcripts is significantly different from one tissue to
another and the ratio is not correlated to the relative level
of expression. For instance, PPARG is expressed at a simi-
lar level in liver and diaphragm while the ratio PPARG/
chimeric transcripts varies from 34 to 108 in these two tis-
sues, respectively. This is most probably due to the varia-
tion in the activity of the different PPARG promoters from
one tissue to another.
The putative chimeric proteins are not detected on bovine 
tissues using immunodetection with an anti-PPARγ 
antibody
We performed Western blot experiments using a commer-
cial anti-PPARγ antibody. This antibody is directed against
a peptide corresponding to the amino-acid residues 284–
298 of mouse PPARγ2 which corresponds to a region
present in both PPARγ1 and PPARγ2. This peptide is fully
conserved in the human PPARγ sequence and differs only
from one amino-acid with the bovine PPARγ sequence. It
corresponds to a region encoded by the beginning of
PPARG exon 5, which means that this region is present in
the putative chimeric protein encoded by the short chi-
meric transcript. Western blots experiments were per-
formed on proteins isolated from human and bovine
subcutaneous adipose tissue, bovine brain and skeletal
muscle (Figure 6). A strong signal was obtained for all tis-
sue at the expected size for PPARγ1 and γ2 (55 to 57 kDa)
but there was no evidence of a larger protein that could
correspond to the chimeric protein which expected size
was estimated to be around 95 kDa.
Chimeric transcripts are not detected in human or mouse
There is no evidence in the databases of any human and
mouse chimeric cDNA or EST implying the PPARG and
TSEN2  genes. We performed RT-PCR experiments on
cDNA isolated from human brain, adipocytes, mammary
gland and skeletal muscle and a set of various mouse tis-
sues (liver, spleen, brain, heart, skeletal muscle and sub-
cutaneous adipose tissue) using primers designed on
PPARG (exon 5 to 6) and TSEN2 (exon 1 to 2). Transcripts
specific of both genes were amplified in all tissues tested
and confirmed by sequencing (data not shown). How-
ever, even though we used several primer sets, we did not
amplify any chimeric transcript.
In the three species, PPARG exon 5 ends after the first
nucleotide of a codon and the junction with TSEN2 exon
2 would reconstitute this codon resulting in an in-frame
connection between the PPARG  and  TSEN2  reading
frames, the latter starting 26, 17 and 20 nucleotides down-
stream in cattle, human and mouse, respectively. How-
ever, whereas this short sequence between the two reading
frames can be translated in cattle, it contains a STOP
codon in human and mouse. Therefore, potential human
or mouse chimeric transcripts with the same structure as
bovine chimeric transcripts would anyway not encode any
chimeric protein.
Discussion
We describe here the existence of bovine chimeric tran-
scripts resulting from intergenic splicing of two neighbor-
ing genes, PPARG, encoding the Peroxisome Proliferator
Activated Receptors γ1 and γ2 and TSEN2, encoding the
tRNA splicing endonuclease 2 homolog. These two genes
are situated about 50 kb apart in the same 5' 3' orientation
on human chromosome 3p25 and bovine chromosome
22q24. We identified two types of chimeric transcripts in
cattle, differing by the presence/absence of an intermedi-
ate exon corresponding to a LINE L2 interspersed
sequence situated in the 5' region of the TSEN2  gene.
There is no evidence of such a mechanism affecting these
two genes in human or mouse. Both types of chimeric
transcripts contain all but the last exon of the PPARG gene
and all but the first exon of the TSEN2 gene, which are
normally the sites of termination and initiation of tran-
scription, respectively. This situation is usually encoun-
tered in intergenic mRNAs resulting from a bypass of
transcriptional termination. However, the reasons why
this occurs are still unknown. Although this kind of event
seems to be very rare, several examples have been
reported, most of them affecting neighboring genes that
are in the same orientation [1,3-6,14,15]. For the several
cases described so far, the physical distance between the
genes involved does not seem to have any influence. The
genes P2RY11 and PPAN are separated by only 400 bp [4],
whereas the DISC1 and TRAX genes are separated by 35 kbBMC Genomics 2006, 7:71 http://www.biomedcentral.com/1471-2164/7/71
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[14] and chimeric transcripts have been observed for
genes of the CYP2C locus that are 26 to 85 kb apart [2].
It is important to be cautious with the interpretation of
"non-conventional" RT-PCR products such as chimeric
transcripts since their existence can sometimes be attrib-
uted to experimental artifacts due to template-switching
activities of the reverse transcriptase (RT) or Taq polymer-
ase [16]. But the structure of the chimeric molecules
appears to be related to the event they derive from, as
shown for the HLA class II genes [17]. Indeed, several lines
of evidence suggest that the molecules we observe here are
not  in vitro artifacts. All transcripts are spliced using
canonical splice sites whereas template switching activity
is independent of splice sites. There is no sequence simi-
larity that could contribute to a homology-dependent
template switching. The fact that the two genes involved
are adjacent to each-other and in the same orientation on
the genome suggests the existence of a co-transcription
unit due to a transcriptional termination bypass. Moreo-
ver, in addition to the transcripts we observed, a bovine
chimeric EST is present in the EST database.
The reason why this mechanism occurs between the
PPARG and TSEN2 genes in cattle but not in human and
mouse is not clear. Furthermore, we observed that chi-
meric mRNA molecules are transcribed from the PPARγ1
promoter only. Both genes are conserved in sequence,
structure, position and orientation in the three species.
Sequence comparison of the PPARγ2 promoter region in
human, mouse and cattle shows a high level of identity
(75 to 80 % on average). The full PPARγ1 promoter
genomic sequence was not available for cattle but it does
not harbor any significant sequence similarity between
human and mouse and the A1 exon is not conserved in
sequence across the three species. This suggests that this
promoter region might have species-specific functions
among which is splicing regulation. Indeed, there is now
evidence that the promoter structure for polymerase II
plays such a role by coupling the transcription and splic-
ing machineries (review in [18]).
The gene fusion event may also be the result of a weak ter-
mination signal for PPARG gene transcription. However,
we demonstrate that normal PPARG  and  TSEN2  tran-
scripts are also expressed, meaning that normal transcrip-
tion termination and co-transcription of the two genes co-
exist. Semi-quantitative RT-PCR showed that the amount
of chimeric transcripts was much lower (up to 124 times
lower in adipose tissue) than the amount of PPARG tran-
scripts, suggesting that this phenomenon is either strictly
regulated, or results from a weak leakage in the cleavage/
polyadenylation of the PPARG  transcripts. A sequence
comparison of the 3'end of the PPARG gene in human,
mouse and cattle revealed a high sequence identity
between the three species. The polyadenylation site in the
three species seems to be situated between a highly con-
served AT-rich sequence and a reasonably conserved GT-
rich sequence. These two structures constitute the most
commonly found features for post-transcriptional
processing. However, there is no obvious difference
between the bovine and the mouse or human sequences
that could explain a malfunction in cattle only. Sequence
analysis shows that the reading frames of both genes can-
not be joined in human and mouse in the same way they
are in the bovine short chimeric transcript. This might
explain why chimeric transcripts are not found in these
two species and would suggest that their presence in cattle
has functional significance.
We could not establish the existence of the chimeric pro-
tein in vivo. This may be due to the fact that the expression
might be very low and thus be undetectable by immuno-
detection, as suggested by the relative quantification of
the different transcripts. It is also possible that the transla-
tion of the chimeric transcripts is subjected to a strict reg-
ulation, i.e they are not translated at all. Indeed, although
fusion transcripts for a number of genes have been
reported, the existence of a fusion protein was reported
only in the case of MASK-4E-BP3 [6]. The functional sig-
nificance of a chimeric protein resulting from the transla-
tion of a fusion transcript between the PPARG and TSEN2
genes is difficult to assess since these two genes have spe-
cific functions that do not have a priori anything in com-
mon. The fusion protein would contain the first 424
amino acids from PPARγ1, the complete Sen2 protein and
an intermediate region of 9 amino-acids resulting from
the translation of the normally-untranslated part of
Relative expression levels of the normal PPARG transcripts  and the chimeric transcripts assessed by semi-quantitative  RT-PCR in four different tissues from one individual Figure 5
Relative expression levels of the normal PPARG transcripts 
and the chimeric transcripts assessed by semi-quantitative 
RT-PCR in four different tissues from one individual. Error 
bars stand for the variation between the values obtained 
from triplicates for each experiment.
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TSEN2  exon 2. Such protein would include the DNA-
binding domain and part of the ligand-binding domain of
PPARγ1 (missing only the 82 amino-acids encoded by
exon 6) and the tRNA intron endonuclease catalytic C ter-
minal domain of Sen2. The Sen2 protein binds to Sen34,
Sen15 and Sen54, forming the tRNA endonuclease com-
plex and was also shown to form complexes with Clp1,
which is a member of the human pre-mRNA 3'end
processing complex, involved in the cleavage/polyade-
nylation of pre-mRNAs [7]. It is puzzling to see that
TSEN2 appears to be involved in a phenomenon presum-
ably due to a malfunction in the mechanisms of pre-
mRNA maturation, while it is precisely one of the func-
tions of the protein encoded by this gene.
The existence of fusion transcripts between unrelated
genes is often referred to as a pathological phenomenon
resulting, for example, from chromosomal translocations
responsible for deregulation of gene expression and onco-
gene activation [19]. But is is tempting to speculate that
non-conventional transcripts may encode new proteins
with new functions. Hybrids between heterologous
mRNAs, generated by mRNA trans-splicing or transcrip-
tion of long mRNA across neighbouring loci may provide
the cell with the potential for evolution and adaptation by
acquiring new functions. With the increasing availability
of sequence data for genomes and transcripts, it is likely
that new cases of chimeric mRNA molecules will be
found. An in-silico based approach on the UNIGENE data-
base revealed that ~1% of the transcripts are chimeric
[20]. Non-linear splice forms can also be generated by
rearrangement or repetition in exon order (RREO), lead-
ing to either shorter reading frames or repetition of a given
domain [21]. These computer-based studies probably give
an over-estimate of the number of such non-conventional
mRNA molecules because of the presence of artefactual
sequences, and their sensitivity needs to be improved.
However, these observations clearly suggest a biological
significance of this phenomenon.
Conclusion
Chimeric mRNA molecules resulting from cotranscription
and trans-splicing of the neighboring genes PPARG and
TSEN2 were indentified in cattle. The existence of these
transcripts appears to be restricted to the bovine species
and is probably the consequence of a modification in the
transcriptional termination regulation. The functional sig-
nificance of this phenomenon, if any, remains to be deter-
mined. However, this might be an example of a way for a
species to increase complexity and diversity at the protein
level.
Methods
RNA extraction and cDNA amplification and sequencing
Total RNA was isolated from bovine (about 400 to 500
mg) and mouse (C57BL/6J) tissue samples, frozen in liq-
uid nitrogen immediately after death, using RNeasy maxi
kit (Qiagen). 1 µg of RNA was reversed transcribed with
oligo-dT primer and the Superscript II RT (Invitrogen).
Several primer pairs were designed on EST sequences and
used to amplify from the cDNA. PCR reactions were car-
ried out in total volumes of 20 µl containing 1/10th of the
RT reaction, 0.2 mM dNTPs, 1.5 mM MgCl2, 10 pmol of
each primer, UptiTherm DNA polymerase and reaction
buffer (Interchim). The cycling conditions included an
initial incubation at 94°C for 2 min followed by 35 cycles
of 30 sec at 94°C, 30 sec at 58°C and 1 min 30 at 72°C.
In some cases, touchdown PCR conditions were used. In
these cases, the annealing temperature was decreased of
one degree per cycle for the first seven cycles and then
maintained constant for the next cycles. PCR products
were purified using the QIAquick PCR purification kit
(Qiagen) and directly sequenced using Big Dye Termina-
Western blot hybridization using an anti-PPARγ antibody on  total protein extracts from 1- human subcutaneous adipose  tissue, 2- bovine subcutaneous adipose tissue, 3- bovine brain  and 4- bovine skeletal muscle Figure 6
Western blot hybridization using an anti-PPARγ antibody on 
total protein extracts from 1- human subcutaneous adipose 
tissue, 2- bovine subcutaneous adipose tissue, 3- bovine brain 
and 4- bovine skeletal muscle.
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tor chemistry (Applied Biosystems) on a ABI PRISM Cycle
sequencing 3100 (Applied Biosystems).
Human cDNA was obtained by reverse transcription of
commercially available RNA from human adipocytes,
brain, mammary gland and skeletal muscle (Clontech).
Semi-quantitative RT-PCR
Total RNA was isolated from bovine tissues (adipocytes,
liver, diaphragm and Rectus abdominalis muscle) using
RNeasy maxi kit (Qiagen). 1 µg of RNA was reverse tran-
scribed using the High-Capacity cDNA Archive kit
(Applied Biosystems). Quantification of PPARG and chi-
meric transcripts from bovine tissues was performed using
SYBR Green (Applied Biosystems) on a ABI Prism 7900HT
Sequence Detection System (Applied Biosystems) in a 20
µl reactions with 2X SYBR Green Master Mix, 300 nM of
each primer and 150 ng RNA. Forward and reverse prim-
ers were placed on two consecutive exons ; primers
sequences are AGCCCTTTGGTGACTTTATGGA (forward
primer in exon 5) and TCCTCAATGGGCTTCACGTT
(reverse primer in exon 6) for PPARG amplification and
TGAAGTTCAACGCACTGGAATT (forward primer in exon
5 of PPARG) and CTGTCGTGCACTCTTCTCTTCCT
(reverse primer in exon 2 of TSEN2) for chimeric tran-
scripts amplification. The reaction conditions involved
denaturation for 10 min at 95°C, and 40 cycles of ampli-
fication with 15 sec at 95°C and 1 min at 60°C. All sam-
ples were analyzed in triplicates, and the data were
normalized using the glyceraldehyde-3-phosphate dehy-
drogenase gene (GAPDH) gene as an internal control.
BAC subcloning and sequencing
BAC clones containing the PPARG and TSEN2 genes were
obtained from the INRA bovine BAC library [22]. BAC
DNA was digested by several restriction enzymes (EcoR I,
Hind III, BamH I) and suitable fragments were detected by
Southern blot using radiolabelled probes corresponding
to TSEN2 exon 1 and 2 and to the LINE L2 intergenic
sequence. The fragments were then gel purified, sub-
cloned into pUC18 vector and sequenced.
Western blots
Total protein extract were prepared from tissue samples
stored at -80°C as described by [23]. Human subcutane-
ous adipose tissue was removed from normal human skin
obtained from abdominal plastic surgery. Protein content
was determined by the Bradford method using BSA as
standard [24]. Total proteins were analyzed by 10% SDS-
PAGE. Gels were electroblotted onto nitro-cellulose mem-
branes, probed with a polyclonal anti-PPARγ1 and γ2
antibody (Calbiochem) and visualised using BM chemilu-
minescence Blotting Substrate (Roche).
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